Related Experiment Video
Updated: Aug 16, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by
Lieve Verlinden1, Guy Eelen, Ine Beullens
1Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Katholieke Universiteit Leuven, Belgium.
Abstract:
1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) has potent antiproliferative effects characterized by a hampered G(1)/S transition. cDNA microarrays were used to monitor expression of 21,492 genes in MC3T3-E1 mouse osteoblasts at 1, 6, 12, 24, and 36 h after treatment with 1,25(OH)(2)D(3). Statistical analysis revealed a cluster of genes that were strongly down-regulated by 1,25(OH)(2)D(3) and which not only function in cell cycle regulation and DNA replication but also mediate checkpoint control, DNA repair, chromosome modifications, and mitosis. Because many of these genes were shown earlier to be regulated by the transcriptional repressor E2F4, the intergenic regions of these 1,25(OH)(2)D(3)-down-regulated genes were searched for the presence of E2F binding sites. This led to the characterization of two novel E2F target genes, chromosome condensation-related SMC-associated protein 1 (Cnap1) and maternal embryonic leucine zipper kinase (Melk). Transfection studies and site-directed mutagenesis confirmed Cnap1 and Melk to be bona fide E2F targets. Repression of Cnap1 and Melk by 1,25(OH)(2)D(3) was confirmed not only in MC3T3-E1 cells but also in several other bone-unrelated cell types. This down-regulation as well as the antiproliferative effect of 1,25(OH)(2)D(3) depended on the pocket proteins p107 and p130 because 1,25(OH)(2)D(3) failed to repress these E2F target genes and lost its antiproliferative action in p107(-/-);p130(-/-) cells but not in pRb(-/-) cells.
Insights
1,25-Dihydroxyvitamin D(3) inhibits cell proliferation by down-regulating E2F target genes, including Cnap1 and Melk. This effect relies on pocket proteins p107 and p130, impacting cell cycle progression in osteoblasts and other cell types.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- 1,25-Dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) exhibits potent antiproliferative effects.
- This action is associated with a hampered G(1)/S cell cycle transition.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the antiproliferative effects of 1,25(OH)(2)D(3) in osteoblasts.
- To identify novel target genes regulated by 1,25(OH)(2)D(3) and the transcription factor E2F.
Main Methods:
- Gene expression profiling using cDNA microarrays in MC3T3-E1 mouse osteoblasts.
- Bioinformatic analysis to identify down-regulated genes and E2F binding sites.
- Transfection studies and site-directed mutagenesis to validate E2F target genes.
Main Results:
- 1,25(OH)(2)D(3) strongly down-regulated genes involved in cell cycle regulation, DNA replication, and mitosis.
- Two novel E2F target genes, Cnap1 and Melk, were identified and validated.
- Down-regulation of Cnap1 and Melk by 1,25(OH)(2)D(3) was observed in multiple cell types.
Conclusions:
- 1,25(OH)(2)D(3) represses novel E2F target genes Cnap1 and Melk, contributing to its antiproliferative effects.
- The antiproliferative action and gene repression by 1,25(OH)(2)D(3) are dependent on pocket proteins p107 and p130, but not pRb.
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Positive Regulator Molecules
Cell Specific Gene Expression
Master Transcription Regulators
Co-activators and Co-repressors

